23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals
Fast Company
23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals
23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals
Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes sensitive data.
 
 
Back to Top